Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INCCPIX · Entity 6757 | Director · Chairman and CEO · 10% owner | March 18, 2026 | March 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CUMBERLAND PHARMACEUTICALS INC
Report date March 18, 2026 · Filed March 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.80 · Expires 2036-03-18 | Direct | 568,000 |
Reported balance
After 2026-03-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-03-18 · Grant · Acquired 100,000 · Balance 568,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 25, 2020 Filed Feb 5, 2021 22:42 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.28 | $49.20 |
DisclosureSEC source: 0001209191-21-008222 · doc5.xml · nonDerivative · entry 5 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,832 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| August 24, 2020 Filed Feb 5, 2021 22:42 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.31 | $49.65 |
DisclosureSEC source: 0001209191-21-008222 · doc5.xml · nonDerivative · entry 4 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,817 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| August 21, 2020 Filed Feb 5, 2021 22:42 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.29 | $49.35 |
DisclosureSEC source: 0001209191-21-008222 · doc5.xml · nonDerivative · entry 3 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,802 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| August 20, 2020 Filed Feb 5, 2021 22:42 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.32 | $49.80 |
DisclosureSEC source: 0001209191-21-008222 · doc5.xml · nonDerivative · entry 2 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,787 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| August 19, 2020 Filed Feb 5, 2021 22:42 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.34 | $50.10 |
DisclosureSEC source: 0001209191-21-008222 · doc5.xml · nonDerivative · entry 1 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,772 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. F2 · shares: Filing 4 of 6. Read SEC document |
| August 18, 2020 Filed Feb 5, 2021 22:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.43 | $51.45 |
DisclosureSEC source: 0001209191-21-008220 · doc5.xml · nonDerivative · entry 30 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,757 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| August 17, 2020 Filed Feb 5, 2021 22:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.35 | $50.25 |
DisclosureSEC source: 0001209191-21-008220 · doc5.xml · nonDerivative · entry 29 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,742 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| August 14, 2020 Filed Feb 5, 2021 22:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.41 | $51.15 |
DisclosureSEC source: 0001209191-21-008220 · doc5.xml · nonDerivative · entry 28 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,727 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| August 13, 2020 Filed Feb 5, 2021 22:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.48 | $52.20 |
DisclosureSEC source: 0001209191-21-008220 · doc5.xml · nonDerivative · entry 27 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,712 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| August 12, 2020 Filed Feb 5, 2021 22:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.48 | $52.20 |
DisclosureSEC source: 0001209191-21-008220 · doc5.xml · nonDerivative · entry 26 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,697 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| August 11, 2020 Filed Feb 5, 2021 22:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.43 | $51.45 |
DisclosureSEC source: 0001209191-21-008220 · doc5.xml · nonDerivative · entry 25 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,682 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| August 10, 2020 Filed Feb 5, 2021 22:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.43 | $51.45 |
DisclosureSEC source: 0001209191-21-008220 · doc5.xml · nonDerivative · entry 24 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,667 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| August 07, 2020 Filed Feb 5, 2021 22:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.43 | $51.45 |
DisclosureSEC source: 0001209191-21-008220 · doc5.xml · nonDerivative · entry 23 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,652 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| August 06, 2020 Filed Feb 5, 2021 22:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.39 | $50.85 |
DisclosureSEC source: 0001209191-21-008220 · doc5.xml · nonDerivative · entry 22 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,637 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| August 05, 2020 Filed Feb 5, 2021 22:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.44 | $51.60 |
DisclosureSEC source: 0001209191-21-008220 · doc5.xml · nonDerivative · entry 21 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,622 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| August 04, 2020 Filed Feb 5, 2021 22:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.41 | $51.15 |
DisclosureSEC source: 0001209191-21-008220 · doc5.xml · nonDerivative · entry 20 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,607 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| August 03, 2020 Filed Feb 5, 2021 22:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.43 | $51.45 |
DisclosureSEC source: 0001209191-21-008220 · doc5.xml · nonDerivative · entry 19 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,592 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| July 31, 2020 Filed Feb 5, 2021 22:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.36 | $50.40 |
DisclosureSEC source: 0001209191-21-008220 · doc5.xml · nonDerivative · entry 18 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,577 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| July 30, 2020 Filed Feb 5, 2021 22:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.22 | $48.30 |
DisclosureSEC source: 0001209191-21-008220 · doc5.xml · nonDerivative · entry 17 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,562 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| July 29, 2020 Filed Feb 5, 2021 22:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.21 | $48.15 |
DisclosureSEC source: 0001209191-21-008220 · doc5.xml · nonDerivative · entry 16 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,547 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| July 28, 2020 Filed Feb 5, 2021 22:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.26 | $48.90 |
DisclosureSEC source: 0001209191-21-008220 · doc5.xml · nonDerivative · entry 15 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,532 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| July 27, 2020 Filed Feb 5, 2021 22:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.28 | $49.20 |
DisclosureSEC source: 0001209191-21-008220 · doc5.xml · nonDerivative · entry 14 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,517 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| July 24, 2020 Filed Feb 5, 2021 22:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.31 | $49.65 |
DisclosureSEC source: 0001209191-21-008220 · doc5.xml · nonDerivative · entry 13 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,502 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| July 23, 2020 Filed Feb 5, 2021 22:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.31 | $49.65 |
DisclosureSEC source: 0001209191-21-008220 · doc5.xml · nonDerivative · entry 12 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,487 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| July 22, 2020 Filed Feb 5, 2021 22:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.22 | $48.30 |
DisclosureSEC source: 0001209191-21-008220 · doc5.xml · nonDerivative · entry 11 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,472 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| July 21, 2020 Filed Feb 5, 2021 22:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.29 | $49.35 |
DisclosureSEC source: 0001209191-21-008220 · doc5.xml · nonDerivative · entry 10 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,457 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| July 20, 2020 Filed Feb 5, 2021 22:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.52 | $52.80 |
DisclosureSEC source: 0001209191-21-008220 · doc5.xml · nonDerivative · entry 9 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,442 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| July 17, 2020 Filed Feb 5, 2021 22:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.33 | $49.95 |
DisclosureSEC source: 0001209191-21-008220 · doc5.xml · nonDerivative · entry 8 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,427 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| July 16, 2020 Filed Feb 5, 2021 22:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.34 | $50.10 |
DisclosureSEC source: 0001209191-21-008220 · doc5.xml · nonDerivative · entry 7 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,412 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| July 15, 2020 Filed Feb 5, 2021 22:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.31 | $49.65 |
DisclosureSEC source: 0001209191-21-008220 · doc5.xml · nonDerivative · entry 6 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,397 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| July 14, 2020 Filed Feb 5, 2021 22:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.26 | $48.90 |
DisclosureSEC source: 0001209191-21-008220 · doc5.xml · nonDerivative · entry 5 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,382 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| July 13, 2020 Filed Feb 5, 2021 22:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.23 | $48.45 |
DisclosureSEC source: 0001209191-21-008220 · doc5.xml · nonDerivative · entry 4 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,367 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| July 10, 2020 Filed Feb 5, 2021 22:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.24 | $48.60 |
DisclosureSEC source: 0001209191-21-008220 · doc5.xml · nonDerivative · entry 3 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,352 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| July 09, 2020 Filed Feb 5, 2021 22:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.27 | $49.05 |
DisclosureSEC source: 0001209191-21-008220 · doc5.xml · nonDerivative · entry 2 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,337 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| July 08, 2020 Filed Feb 5, 2021 22:41 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.33 | $49.95 |
DisclosureSEC source: 0001209191-21-008220 · doc5.xml · nonDerivative · entry 1 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,322 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. F2 · shares: Filing 3 of 6. Read SEC document |
| July 07, 2020 Filed Feb 5, 2021 22:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.35 | $50.25 |
DisclosureSEC source: 0001209191-21-008218 · doc5.xml · nonDerivative · entry 30 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,307 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| July 06, 2020 Filed Feb 5, 2021 22:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.36 | $50.40 |
DisclosureSEC source: 0001209191-21-008218 · doc5.xml · nonDerivative · entry 29 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,292 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| July 02, 2020 Filed Feb 5, 2021 22:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.31 | $49.65 |
DisclosureSEC source: 0001209191-21-008218 · doc5.xml · nonDerivative · entry 28 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,277 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| July 01, 2020 Filed Feb 5, 2021 22:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.38 | $50.70 |
DisclosureSEC source: 0001209191-21-008218 · doc5.xml · nonDerivative · entry 27 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,262 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| June 30, 2020 Filed Feb 5, 2021 22:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.35 | $50.25 |
DisclosureSEC source: 0001209191-21-008218 · doc5.xml · nonDerivative · entry 26 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,247 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| June 29, 2020 Filed Feb 5, 2021 22:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.32 | $49.80 |
DisclosureSEC source: 0001209191-21-008218 · doc5.xml · nonDerivative · entry 25 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,232 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| June 26, 2020 Filed Feb 5, 2021 22:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.31 | $49.65 |
DisclosureSEC source: 0001209191-21-008218 · doc5.xml · nonDerivative · entry 24 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,217 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| June 25, 2020 Filed Feb 5, 2021 22:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.41 | $51.15 |
DisclosureSEC source: 0001209191-21-008218 · doc5.xml · nonDerivative · entry 23 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,202 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| June 24, 2020 Filed Feb 5, 2021 22:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.39 | $50.85 |
DisclosureSEC source: 0001209191-21-008218 · doc5.xml · nonDerivative · entry 22 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,187 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| June 23, 2020 Filed Feb 5, 2021 22:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.41 | $51.15 |
DisclosureSEC source: 0001209191-21-008218 · doc5.xml · nonDerivative · entry 21 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,172 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| June 22, 2020 Filed Feb 5, 2021 22:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.35 | $50.25 |
DisclosureSEC source: 0001209191-21-008218 · doc5.xml · nonDerivative · entry 20 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,157 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| June 19, 2020 Filed Feb 5, 2021 22:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.42 | $51.30 |
DisclosureSEC source: 0001209191-21-008218 · doc5.xml · nonDerivative · entry 19 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,142 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| June 18, 2020 Filed Feb 5, 2021 22:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.41 | $51.15 |
DisclosureSEC source: 0001209191-21-008218 · doc5.xml · nonDerivative · entry 18 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,127 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| June 17, 2020 Filed Feb 5, 2021 22:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.41 | $51.15 |
DisclosureSEC source: 0001209191-21-008218 · doc5.xml · nonDerivative · entry 17 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,112 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
| June 16, 2020 Filed Feb 5, 2021 22:40 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | OtherCommon Stock | 15 | $3.46 | $51.90 |
DisclosureSEC source: 0001209191-21-008218 · doc5.xml · nonDerivative · entry 16 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,791,097 F1 · shares: The purchase reported in this Form 5 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.